Structure

Physi-Chem Properties

Molecular Weight:  530.25
Volume:  542.491
LogP:  3.71
LogD:  3.136
LogS:  -4.404
# Rotatable Bonds:  9
TPSA:  101.91
# H-Bond Aceptor:  9
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.377
Synthetic Accessibility Score:  4.003
Fsp3:  0.483
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.618
MDCK Permeability:  2.202860741817858e-05
Pgp-inhibitor:  0.997
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.096

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.058
Plasma Protein Binding (PPB):  61.98978042602539%
Volume Distribution (VD):  0.744
Pgp-substrate:  29.547855377197266%

ADMET: Metabolism

CYP1A2-inhibitor:  0.048
CYP1A2-substrate:  0.989
CYP2C19-inhibitor:  0.585
CYP2C19-substrate:  0.936
CYP2C9-inhibitor:  0.478
CYP2C9-substrate:  0.802
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.857
CYP3A4-inhibitor:  0.853
CYP3A4-substrate:  0.904

ADMET: Excretion

Clearance (CL):  6.069
Half-life (T1/2):  0.111

ADMET: Toxicity

hERG Blockers:  0.209
Human Hepatotoxicity (H-HT):  0.074
Drug-inuced Liver Injury (DILI):  0.408
AMES Toxicity:  0.052
Rat Oral Acute Toxicity:  0.286
Maximum Recommended Daily Dose:  0.045
Skin Sensitization:  0.169
Carcinogencity:  0.021
Eye Corrosion:  0.003
Eye Irritation:  0.155
Respiratory Toxicity:  0.707

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC295297

Natural Product ID:  NPC295297
Common Name*:   RHABJANPSGWEFC-MRFZJNLZSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  RHABJANPSGWEFC-MRFZJNLZSA-N
Standard InCHI:  InChI=1S/C29H38O9/c1-11-15(2)28(30)38-27-18-14-20(33-6)24(35-8)26(37-10)22(18)21-17(12-16(3)29(27,4)31)13-19(32-5)23(34-7)25(21)36-9/h11,13-14,16,27,31H,12H2,1-10H3/b15-11-/t16-,27-,29-/m0/s1
SMILES:  C/C=C(C(=O)O[C@H]1c2cc(OC)c(c(c2c2c(C[C@@H]([C@]1(C)O)C)cc(c(c2OC)OC)OC)OC)OC)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2386337
PubChem CID:   14992071
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29191 Schisandra neglecta Species Schisandraceae Eukaryota Stems Luoji Mountain Village, Xichang County, Sicuan Province, China 2011-Sep PMID[23738539]
NPO29191 Schisandra neglecta Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 = 84700.0 nM PMID[553251]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 10000.0 nM PMID[553251]
NPT306 Cell Line PC-3 Homo sapiens IC50 > 10000.0 nM PMID[553251]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[553251]
NPT2678 Cell Line NB-4 Homo sapiens IC50 > 10000.0 nM PMID[553251]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 11500.0 nM PMID[553251]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 7800.0 nM PMID[553251]
NPT27 Others Unspecified Ratio CC50/EC50 = 7.4 n.a. PMID[553251]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC295297 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9789 High Similarity NPC470916
0.9718 High Similarity NPC474347
0.9718 High Similarity NPC474393
0.9586 High Similarity NPC16791
0.9586 High Similarity NPC126405
0.9586 High Similarity NPC53669
0.9586 High Similarity NPC217708
0.9586 High Similarity NPC77237
0.9586 High Similarity NPC308739
0.9586 High Similarity NPC297271
0.9577 High Similarity NPC183083
0.9577 High Similarity NPC137352
0.9514 High Similarity NPC477381
0.9452 High Similarity NPC149735
0.9448 High Similarity NPC477379
0.9448 High Similarity NPC224472
0.9388 High Similarity NPC473736
0.9388 High Similarity NPC198461
0.9371 High Similarity NPC474054
0.9366 High Similarity NPC87883
0.9353 High Similarity NPC865
0.9329 High Similarity NPC475592
0.9324 High Similarity NPC476065
0.932 High Similarity NPC475141
0.932 High Similarity NPC24562
0.9241 High Similarity NPC252281
0.9241 High Similarity NPC327352
0.9241 High Similarity NPC477375
0.9241 High Similarity NPC198129
0.9241 High Similarity NPC477879
0.9178 High Similarity NPC322426
0.9178 High Similarity NPC477374
0.9178 High Similarity NPC477376
0.9133 High Similarity NPC473323
0.9128 High Similarity NPC312763
0.9122 High Similarity NPC471154
0.9116 High Similarity NPC316989
0.9085 High Similarity NPC42797
0.906 High Similarity NPC474606
0.9054 High Similarity NPC475756
0.9048 High Similarity NPC85141
0.9034 High Similarity NPC318286
0.9034 High Similarity NPC327651
0.9026 High Similarity NPC291977
0.9014 High Similarity NPC471183
0.9013 High Similarity NPC215400
0.9013 High Similarity NPC230531
0.9007 High Similarity NPC29727
0.8993 High Similarity NPC102256
0.898 High Similarity NPC325720
0.898 High Similarity NPC316676
0.8973 High Similarity NPC321958
0.8973 High Similarity NPC321696
0.8966 High Similarity NPC326144
0.8961 High Similarity NPC473445
0.894 High Similarity NPC238834
0.8933 High Similarity NPC477377
0.8921 High Similarity NPC184928
0.8921 High Similarity NPC141493
0.891 High Similarity NPC83049
0.891 High Similarity NPC320471
0.891 High Similarity NPC118162
0.8897 High Similarity NPC218510
0.8897 High Similarity NPC76415
0.8889 High Similarity NPC328122
0.8874 High Similarity NPC473425
0.8873 High Similarity NPC133025
0.8867 High Similarity NPC477378
0.8867 High Similarity NPC475229
0.8859 High Similarity NPC473989
0.8839 High Similarity NPC249070
0.8811 High Similarity NPC156948
0.8811 High Similarity NPC3072
0.8811 High Similarity NPC301765
0.8811 High Similarity NPC86605
0.8811 High Similarity NPC46277
0.8803 High Similarity NPC214853
0.8803 High Similarity NPC55239
0.8803 High Similarity NPC180602
0.8803 High Similarity NPC240279
0.8767 High Similarity NPC469630
0.8758 High Similarity NPC477380
0.8758 High Similarity NPC469474
0.875 High Similarity NPC348849
0.875 High Similarity NPC178195
0.8734 High Similarity NPC79322
0.8732 High Similarity NPC469659
0.8732 High Similarity NPC56764
0.8732 High Similarity NPC188378
0.8732 High Similarity NPC276026
0.8732 High Similarity NPC555
0.8732 High Similarity NPC289258
0.8732 High Similarity NPC7515
0.8732 High Similarity NPC206737
0.8725 High Similarity NPC252402
0.8725 High Similarity NPC102934
0.871 High Similarity NPC63061
0.8705 High Similarity NPC149008
0.8705 High Similarity NPC283114
0.8705 High Similarity NPC207702
0.8701 High Similarity NPC477885
0.8679 High Similarity NPC88557
0.8658 High Similarity NPC178129
0.8639 High Similarity NPC324962
0.8625 High Similarity NPC477883
0.8621 High Similarity NPC53722
0.8621 High Similarity NPC290714
0.8621 High Similarity NPC201404
0.8616 High Similarity NPC311912
0.8611 High Similarity NPC471719
0.8591 High Similarity NPC205361
0.8581 High Similarity NPC121661
0.8581 High Similarity NPC143092
0.8581 High Similarity NPC18211
0.8581 High Similarity NPC73467
0.8571 High Similarity NPC36531
0.8571 High Similarity NPC229172
0.8571 High Similarity NPC230538
0.8571 High Similarity NPC103637
0.8553 High Similarity NPC303519
0.8535 High Similarity NPC319749
0.8533 High Similarity NPC15577
0.8526 High Similarity NPC325122
0.8523 High Similarity NPC110763
0.8523 High Similarity NPC189239
0.8523 High Similarity NPC475868
0.8523 High Similarity NPC197352
0.8523 High Similarity NPC166506
0.8519 High Similarity NPC477881
0.8503 High Similarity NPC300611
0.8497 Intermediate Similarity NPC272566
0.8497 Intermediate Similarity NPC476434
0.8497 Intermediate Similarity NPC228662
0.8487 Intermediate Similarity NPC24425
0.8483 Intermediate Similarity NPC471988
0.8481 Intermediate Similarity NPC280778
0.8481 Intermediate Similarity NPC469512
0.8477 Intermediate Similarity NPC93924
0.8477 Intermediate Similarity NPC476348
0.8477 Intermediate Similarity NPC187398
0.8472 Intermediate Similarity NPC309744
0.8472 Intermediate Similarity NPC135127
0.8471 Intermediate Similarity NPC24627
0.8467 Intermediate Similarity NPC40222
0.8467 Intermediate Similarity NPC252286
0.8467 Intermediate Similarity NPC154971
0.8467 Intermediate Similarity NPC268515
0.8462 Intermediate Similarity NPC475856
0.8462 Intermediate Similarity NPC125495
0.8456 Intermediate Similarity NPC239254
0.8456 Intermediate Similarity NPC172171
0.8452 Intermediate Similarity NPC476642
0.8451 Intermediate Similarity NPC79184
0.8451 Intermediate Similarity NPC476399
0.8451 Intermediate Similarity NPC307042
0.8446 Intermediate Similarity NPC184641
0.8446 Intermediate Similarity NPC133934
0.8446 Intermediate Similarity NPC184684
0.8446 Intermediate Similarity NPC67467
0.8446 Intermediate Similarity NPC287124
0.8442 Intermediate Similarity NPC65591
0.8442 Intermediate Similarity NPC178574
0.8428 Intermediate Similarity NPC469518
0.8428 Intermediate Similarity NPC469475
0.8425 Intermediate Similarity NPC281780
0.8421 Intermediate Similarity NPC176903
0.8421 Intermediate Similarity NPC30688
0.8418 Intermediate Similarity NPC258322
0.8418 Intermediate Similarity NPC191352
0.8414 Intermediate Similarity NPC311430
0.8414 Intermediate Similarity NPC224941
0.8411 Intermediate Similarity NPC476347
0.8408 Intermediate Similarity NPC241600
0.8408 Intermediate Similarity NPC173726
0.84 Intermediate Similarity NPC163898
0.84 Intermediate Similarity NPC477702
0.8389 Intermediate Similarity NPC470811
0.8389 Intermediate Similarity NPC477697
0.8389 Intermediate Similarity NPC6568
0.8389 Intermediate Similarity NPC477696
0.8389 Intermediate Similarity NPC138212
0.8377 Intermediate Similarity NPC95498
0.8377 Intermediate Similarity NPC302610
0.8377 Intermediate Similarity NPC246566
0.8375 Intermediate Similarity NPC477884
0.8369 Intermediate Similarity NPC242032
0.8367 Intermediate Similarity NPC230124
0.8367 Intermediate Similarity NPC6300
0.8367 Intermediate Similarity NPC114171
0.8366 Intermediate Similarity NPC294522
0.8366 Intermediate Similarity NPC21184
0.8366 Intermediate Similarity NPC120426
0.8366 Intermediate Similarity NPC205727
0.8364 Intermediate Similarity NPC477882
0.8364 Intermediate Similarity NPC477880
0.8356 Intermediate Similarity NPC143895
0.8355 Intermediate Similarity NPC304821
0.8355 Intermediate Similarity NPC473408
0.8355 Intermediate Similarity NPC236166
0.8345 Intermediate Similarity NPC145722

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC295297 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8205 Intermediate Similarity NPD37 Approved
0.8176 Intermediate Similarity NPD6234 Discontinued
0.8165 Intermediate Similarity NPD4966 Approved
0.8165 Intermediate Similarity NPD4967 Phase 2
0.8165 Intermediate Similarity NPD4965 Approved
0.8125 Intermediate Similarity NPD3027 Phase 3
0.805 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5844 Phase 1
0.7988 Intermediate Similarity NPD7473 Discontinued
0.7963 Intermediate Similarity NPD7199 Phase 2
0.7939 Intermediate Similarity NPD7228 Approved
0.7925 Intermediate Similarity NPD1465 Phase 2
0.7914 Intermediate Similarity NPD6232 Discontinued
0.7875 Intermediate Similarity NPD3817 Phase 2
0.7866 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD1613 Approved
0.7834 Intermediate Similarity NPD1653 Approved
0.7812 Intermediate Similarity NPD7819 Suspended
0.7751 Intermediate Similarity NPD7240 Approved
0.775 Intermediate Similarity NPD1934 Approved
0.774 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD4060 Phase 1
0.7703 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD7266 Discontinued
0.7619 Intermediate Similarity NPD3018 Phase 2
0.7613 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD7075 Discontinued
0.755 Intermediate Similarity NPD6355 Discontinued
0.7548 Intermediate Similarity NPD6674 Discontinued
0.7547 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD5763 Approved
0.7532 Intermediate Similarity NPD5762 Approved
0.753 Intermediate Similarity NPD8127 Discontinued
0.7529 Intermediate Similarity NPD7074 Phase 3
0.7515 Intermediate Similarity NPD3818 Discontinued
0.75 Intermediate Similarity NPD3882 Suspended
0.75 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7549 Discontinued
0.75 Intermediate Similarity NPD3750 Approved
0.75 Intermediate Similarity NPD6166 Phase 2
0.75 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD2801 Approved
0.7471 Intermediate Similarity NPD7054 Approved
0.747 Intermediate Similarity NPD5494 Approved
0.7468 Intermediate Similarity NPD6799 Approved
0.7466 Intermediate Similarity NPD2983 Phase 2
0.7466 Intermediate Similarity NPD2982 Phase 2
0.7466 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6190 Approved
0.745 Intermediate Similarity NPD4908 Phase 1
0.7448 Intermediate Similarity NPD3705 Approved
0.7436 Intermediate Similarity NPD1652 Phase 2
0.7434 Intermediate Similarity NPD5124 Phase 1
0.7434 Intermediate Similarity NPD230 Phase 1
0.7434 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD5283 Phase 1
0.7427 Intermediate Similarity NPD7472 Approved
0.7407 Intermediate Similarity NPD6599 Discontinued
0.7407 Intermediate Similarity NPD4380 Phase 2
0.7403 Intermediate Similarity NPD3748 Approved
0.74 Intermediate Similarity NPD4625 Phase 3
0.74 Intermediate Similarity NPD7095 Approved
0.7397 Intermediate Similarity NPD2981 Phase 2
0.7389 Intermediate Similarity NPD4628 Phase 3
0.7381 Intermediate Similarity NPD7229 Phase 3
0.7361 Intermediate Similarity NPD5691 Approved
0.7358 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2438 Suspended
0.7351 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD5536 Phase 2
0.7333 Intermediate Similarity NPD5353 Approved
0.7333 Intermediate Similarity NPD5402 Approved
0.7329 Intermediate Similarity NPD1610 Phase 2
0.7329 Intermediate Similarity NPD422 Phase 1
0.7317 Intermediate Similarity NPD6801 Discontinued
0.7315 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD2534 Approved
0.7312 Intermediate Similarity NPD2533 Approved
0.7312 Intermediate Similarity NPD2532 Approved
0.731 Intermediate Similarity NPD4626 Approved
0.7299 Intermediate Similarity NPD7808 Phase 3
0.7299 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD7768 Phase 2
0.7288 Intermediate Similarity NPD6842 Approved
0.7288 Intermediate Similarity NPD6843 Phase 3
0.7288 Intermediate Similarity NPD6841 Approved
0.7278 Intermediate Similarity NPD4110 Phase 3
0.7278 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD5089 Approved
0.7256 Intermediate Similarity NPD5090 Approved
0.725 Intermediate Similarity NPD4357 Discontinued
0.725 Intermediate Similarity NPD1511 Approved
0.7246 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD2935 Discontinued
0.7244 Intermediate Similarity NPD6099 Approved
0.7244 Intermediate Similarity NPD6100 Approved
0.7241 Intermediate Similarity NPD7251 Discontinued
0.7241 Intermediate Similarity NPD7685 Pre-registration
0.7241 Intermediate Similarity NPD6559 Discontinued
0.7237 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD6798 Discontinued
0.7235 Intermediate Similarity NPD5242 Approved
0.723 Intermediate Similarity NPD4749 Approved
0.7226 Intermediate Similarity NPD7097 Phase 1
0.7222 Intermediate Similarity NPD5403 Approved
0.7219 Intermediate Similarity NPD6959 Discontinued
0.7216 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD3751 Discontinued
0.7205 Intermediate Similarity NPD5401 Approved
0.7202 Intermediate Similarity NPD919 Approved
0.7184 Intermediate Similarity NPD6797 Phase 2
0.7181 Intermediate Similarity NPD1283 Approved
0.7176 Intermediate Similarity NPD3787 Discontinued
0.7169 Intermediate Similarity NPD8455 Phase 2
0.716 Intermediate Similarity NPD1512 Approved
0.7152 Intermediate Similarity NPD7411 Suspended
0.7152 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD2861 Phase 2
0.7143 Intermediate Similarity NPD2979 Phase 3
0.7143 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3620 Phase 2
0.7135 Intermediate Similarity NPD8434 Phase 2
0.7135 Intermediate Similarity NPD3926 Phase 2
0.7134 Intermediate Similarity NPD4005 Discontinued
0.7134 Intermediate Similarity NPD2796 Approved
0.7134 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD2797 Approved
0.7126 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD447 Suspended
0.7089 Intermediate Similarity NPD3540 Phase 1
0.7078 Intermediate Similarity NPD6233 Phase 2
0.7072 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD1510 Phase 2
0.7063 Intermediate Similarity NPD8166 Discontinued
0.7063 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD1548 Phase 1
0.7051 Intermediate Similarity NPD6653 Approved
0.7048 Intermediate Similarity NPD6386 Approved
0.7048 Intermediate Similarity NPD6385 Approved
0.7047 Intermediate Similarity NPD1608 Approved
0.7044 Intermediate Similarity NPD1549 Phase 2
0.7044 Intermediate Similarity NPD2424 Discontinued
0.7041 Intermediate Similarity NPD3749 Approved
0.7041 Intermediate Similarity NPD4055 Discovery
0.7032 Intermediate Similarity NPD4140 Approved
0.7032 Intermediate Similarity NPD1240 Approved
0.703 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD3496 Discontinued
0.7025 Intermediate Similarity NPD6032 Approved
0.7025 Intermediate Similarity NPD3539 Phase 1
0.7025 Intermediate Similarity NPD1551 Phase 2
0.7024 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD3268 Approved
0.7013 Intermediate Similarity NPD7985 Registered
0.7 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1358 Approved
0.7 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.6994 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6994 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6993 Remote Similarity NPD6832 Phase 2
0.6981 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6981 Remote Similarity NPD1552 Clinical (unspecified phase)
0.698 Remote Similarity NPD1281 Approved
0.698 Remote Similarity NPD1611 Approved
0.6975 Remote Similarity NPD7124 Phase 2
0.6971 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6968 Remote Similarity NPD7680 Approved
0.6966 Remote Similarity NPD7157 Approved
0.6966 Remote Similarity NPD8312 Approved
0.6966 Remote Similarity NPD8313 Approved
0.6964 Remote Similarity NPD4585 Approved
0.6962 Remote Similarity NPD7033 Discontinued
0.6962 Remote Similarity NPD2799 Discontinued
0.6957 Remote Similarity NPD3892 Phase 2
0.6957 Remote Similarity NPD7003 Approved
0.6951 Remote Similarity NPD6273 Approved
0.6943 Remote Similarity NPD1607 Approved
0.6929 Remote Similarity NPD3134 Approved
0.6928 Remote Similarity NPD3226 Approved
0.6923 Remote Similarity NPD228 Approved
0.6923 Remote Similarity NPD2238 Phase 2
0.6919 Remote Similarity NPD1247 Approved
0.6914 Remote Similarity NPD2677 Approved
0.6903 Remote Similarity NPD3764 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data